SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061996
Filing Date
2023-11-09
Accepted
2023-11-09 16:04:53
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spry-20230930.htm   iXBRL 10-Q 2692427
2 EX-31.1 spry-ex31_1.htm EX-31.1 16583
3 EX-31.2 spry-ex31_2.htm EX-31.2 16570
4 EX-32.1 spry-ex32_1.htm EX-32.1 20965
  Complete submission text file 0000950170-23-061996.txt   8268420

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spry-20230930.xsd EX-101.SCH 54947
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spry-20230930_pre.xml EX-101.PRE 330134
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spry-20230930_def.xml EX-101.DEF 189938
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spry-20230930_lab.xml EX-101.LAB 444738
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spry-20230930_cal.xml EX-101.CAL 44443
62 EXTRACTED XBRL INSTANCE DOCUMENT spry-20230930_htm.xml XML 1193695
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 231392238
SIC: 2834 Pharmaceutical Preparations